| Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study A Clark, M Jit, C Warren-Gash, B Guthrie, HHX Wang, SW Mercer, ... The Lancet Global Health 8 (8), e1003-e1017, 2020 | 1138 | 2020 |
| Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study AJ Kucharski, P Klepac, AJK Conlan, SM Kissler, ML Tang, H Fry, JR Gog, ... The Lancet infectious diseases 20 (10), 1151-1160, 2020 | 1045 | 2020 |
| Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study NG Davies, AJ Kucharski, RM Eggo, A Gimma, WJ Edmunds, T Jombart, ... The Lancet Public Health 5 (7), e375-e385, 2020 | 899 | 2020 |
| Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection K Abbas, SR Procter, K van Zandvoort, A Clark, S Funk, T Mengistu, ... The Lancet Global Health 8 (10), e1264-e1272, 2020 | 393 | 2020 |
| Schistosomiasis—assessing progress toward the 2020 and 2025 global goals AK Deol, FM Fleming, B Calvo-Urbano, M Walker, V Bucumi, I Gnandou, ... New England Journal of Medicine 381 (26), 2519-2528, 2019 | 194 | 2019 |
| An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary … KME Turner, J Round, P Horner, J Macleod, S Goldenberg, A Deol, ... Sexually transmitted infections 90 (2), 104-111, 2014 | 93 | 2014 |
| Population genetic structure of Schistosoma mansoni and Schistosoma haematobium from across six sub-Saharan African countries: implications for epidemiology, evolution and control CM Gower, AN Gouvras, PHL Lamberton, A Deol, J Shrivastava, ... Acta tropica 128 (2), 261-274, 2013 | 87 | 2013 |
| Evaluating the variation in the projected benefit of community-wide mass treatment for schistosomiasis: Implications for future economic evaluations HC Turner, JE Truscott, AA Bettis, SH Farrell, AK Deol, JM Whitton, ... Parasites & vectors 10, 1-15, 2017 | 48 | 2017 |
| Associations between infection intensity categories and morbidity prevalence in school-age children are much stronger for Schistosoma haematobium than for S. mansoni RE Wiegand, WE Secor, FM Fleming, MD French, CH King, AK Deol, ... PLoS neglected tropical diseases 15 (5), e0009444, 2021 | 26 | 2021 |
| The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study RA Clark, C Mukandavire, A Portnoy, CK Weerasuriya, A Deol, ... The Lancet Global Health 11 (4), e546-e555, 2023 | 25 | 2023 |
| The cost and cost-effectiveness of novel tuberculosis vaccines in low-and middle-income countries: A modeling study A Portnoy, RA Clark, M Quaife, CK Weerasuriya, C Mukandavire, ... PLoS medicine 20 (1), e1004155, 2023 | 25 | 2023 |
| Urogenital schistosomiasis in Cabo Delgado, northern Mozambique: baseline findings from the SCORE study AE Phillips, PH Gazzinelli-Guimarães, HO Aurelio, N Dhanani, J Ferro, ... Parasites & vectors 11, 1-10, 2018 | 19 | 2018 |
| Strategic considerations on developing a CHIKV vaccine and ensuring equitable access for countries in need N Cherian, A Bettis, A Deol, A Kumar, JL Di Fabio, A Chaudhari, S Yimer, ... npj Vaccines 8 (1), 123, 2023 | 16 | 2023 |
| Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens AK Deol, D Scarponi, P Beckwith, TA Yates, AS Karat, AWC Yan, ... PLoS One 16 (6), e0253096, 2021 | 16 | 2021 |
| Modelling the effect of infection prevention and control measures on rate of Mycobacterium tuberculosis transmission to clinic attendees in primary health clinics in South Africa N McCreesh, AS Karat, K Baisley, K Diaconu, F Bozzani, I Govender, ... BMJ global health 6 (10), e007124, 2021 | 13 | 2021 |
| Development and evaluation of a Markov model to predict changes in schistosomiasis prevalence in response to praziquantel treatment: a case study of Schistosoma mansoni in … A Deol, JP Webster, M Walker, MG Basáñez, TD Hollingsworth, ... Parasites & vectors 9, 1-15, 2016 | 9 | 2016 |
| Demonstrating multi-country calibration of a tuberculosis model using new history matching and emulation package-hmer D Scarponi, A Iskauskas, RA Clark, I Vernon, TJ McKinley, M Goldstein, ... Epidemics 43, 100678, 2023 | 8 | 2023 |
| Markov model predicts changes in STH prevalence during control activities even with a reduced amount of baseline information A Montresor, A Deol, N à Porta, N Lethanh, D Jankovic PLoS neglected tropical diseases 10 (4), e0004371, 2016 | 8* | 2016 |
| Importance of ventilation and occupancy to Mycobacterium tuberculosis transmission rates in congregate settings AK Deol, N Shaikh, K Middelkoop, M Mohlamonyane, RG White, ... BMC public health 22 (1), 1772, 2022 | 3 | 2022 |
| The impact of alternative delivery strategies for novel tuberculosis vaccines in low-and middle-income countries: A modelling study [Preprint]. Public and Global Health RA Clark, C Mukandavire, A Portnoy, CK Weerasuriya, A Deol, ... Health. https://doi. org/10.1101/2022.04 16, 2022 | 3 | 2022 |
